Literature DB >> 23064532

A randomized trial of home versus clinic-based sexually transmitted disease screening among men.

Mary M Reagan1, Hanna Xu, Shirley L Shih, Gina M Secura, Jeffrey F Peipert.   

Abstract

BACKGROUND: Preventing sexually transmitted diseases (STD) such as Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) remains a public health challenge. The U.S. Preventive Services Task Force suggests STD screening among men will likely lead to a decrease in infection rates of women. However, innovative approaches are necessary to increase the traditionally low rates of male screening. The purpose of this study is to compare the acceptability and effectiveness of home-based versus clinic-based urine screening for CT and GC in men.
METHODS: We conducted a randomized clinical trial of 200 men aged 18 to 45 years who reside in St. Louis, MO. Men were enrolled via telephone and randomly assigned to receive a free urine CT/GC screening kit either in-person at the research clinic or to have it mailed to the participant's preferred address. Participants completed questionnaires at baseline and 10 to 12 weeks postenrollment. The primary outcome was whether STD screening was completed.
RESULTS: Sixty percent (120/200) completed STD screening. Men assigned to home-based screening were 60% more likely to complete screening compared with clinic-based screening (72% vs. 48%, RRadj = 1.6, 95% CI = 1.3, 2.00). We identified 4 cases of CT or GC in the home-based group compared with 3 cases of CT in the clinic group. Men who completed screening were significantly more likely to be white, younger, and college educated.
CONCLUSIONS: Home-based screening for CT and GC among men is more acceptable than clinic-based screening and resulted in higher rates of screening completion. Incorporating home-based methods as adjuncts to traditional STD screening options shows promise in improving STD screening rates in men.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064532      PMCID: PMC3476063          DOI: 10.1097/OLQ.0b013e3182649165

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  20 in total

1.  Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men.

Authors:  Shua J Chai; Bulbulgul Aumakhan; Mathilda Barnes; Mary Jett-Goheen; Nicole Quinn; Patricia Agreda; Pamela Whittle; Terry Hogan; Wiley D Jenkins; Cornelis A Rietmeijer; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2010-12       Impact factor: 2.830

2.  Acceptability and consequences of screening for chlamydia trachomatis by home-based urine testing.

Authors:  Hannelore M Götz; Irene K Veldhuijzen; Jan E A M van Bergen; Christian J P A Hoebe; Onno de Zwart; Jan H Richardus; J E A M van Bergen; J Broer; A J J Coenen; H M Götz; F de Groot; C J P A Hoebe; J H Richardus; D T van Schaik; I K Veldhuijzen; M J C Verhooren
Journal:  Sex Transm Dis       Date:  2005-09       Impact factor: 2.830

3.  Screening for testicular cancer: recommendation statement.

Authors:  Ned Calonge
Journal:  Am Fam Physician       Date:  2005-11-15       Impact factor: 3.292

4.  Social and behavioral correlates of pelvic inflammatory disease.

Authors:  S O Aral; J N Wasserheit
Journal:  Sex Transm Dis       Date:  1998-08       Impact factor: 2.830

5.  Effectiveness of a mass media campaign to recruit young adults for testing of Chlamydia trachomatis by use of home obtained and mailed samples.

Authors:  B Andersen; L Østergaard; J K Møller; F Olesen
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

6.  Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands.

Authors:  J van Bergen; H M Götz; J H Richardus; C J P A Hoebe; J Broer; A J T Coenen
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

7.  Urine screening for gonococcal and chlamydial infections at community-based organizations in a high-morbidity area.

Authors:  C A Jones; R C Knaup; M Hayes; B P Stoner
Journal:  Sex Transm Dis       Date:  2000-03       Impact factor: 2.830

8.  Screening high-risk adolescent males for Chlamydia trachomatis infection. Obtaining urine specimens in the field.

Authors:  R A Gunn; G D Podschun; S Fitzgerald; M F Hovell; C E Farshy; C M Black; J R Greenspan
Journal:  Sex Transm Dis       Date:  1998-01       Impact factor: 2.830

9.  The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection.

Authors:  Robert C Brunham; Babak Pourbohloul; Sunny Mak; Rick White; Michael L Rekart
Journal:  J Infect Dis       Date:  2005-10-10       Impact factor: 5.226

10.  The prevalence of Chlamydia trachomatis infection in male undergraduates: a postal survey.

Authors:  K E Rogstad; S M Bates; S Partridge; G Kudesia; R Poll; M A Osborne; S Dixon
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

View more
  12 in total

Review 1.  Point of care diagnostics for sexually transmitted infections: perspectives and advances.

Authors:  Charlotte Gaydos; Justin Hardick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-02-03       Impact factor: 5.091

2.  Could home sexually transmitted infection specimen collection with e-prescription be a cost-effective strategy for clinical trials and clinical care?

Authors:  Diane R Blake; Freya Spielberg; Vivian Levy; Shelly Lensing; Peter A Wolff; Lalitha Venkatasubramanian; Nincoshka Acevedo; Nancy Padian; Ishita Chattopadhyay; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2015-01       Impact factor: 2.830

3.  Trichomonas vaginalis infection in men who submit self-collected penile swabs after internet recruitment.

Authors:  Charlotte A Gaydos; Mathilda R Barnes; Nicole Quinn; Mary Jett-Goheen; Yu-Hsiang Hsieh
Journal:  Sex Transm Infect       Date:  2013-01-26       Impact factor: 3.519

Review 4.  Bacterial Sexually Transmitted Disease Screening Outside the Clinic--Implications for the Modern Sexually Transmitted Disease Program.

Authors:  Kyle T Bernstein; Joan M Chow; Preeti Pathela; Thomas L Gift
Journal:  Sex Transm Dis       Date:  2016-02       Impact factor: 2.830

5.  Acceptability and feasibility of a Peer Mentor program to train young Black men who have sex with men to promote HIV and STI home-testing to their social network members.

Authors:  Karin Tobin; Catie Edwards; Natalie Flath; Alexandra Lee; Kayla Tormohlen; Charlotte A Gaydos
Journal:  AIDS Care       Date:  2018-02-26

6.  Notes from the field: increase in gonorrhea cases in counties associated with American Indian Reservations -- Montana, January 2012-August 2014.

Authors:  Randall J Nett; Peter Choi; Cara Murolo; James S Murphy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-10-17       Impact factor: 17.586

Review 7.  Obtaining self-samples to diagnose curable sexually transmitted infections: a systematic review of patients' experiences.

Authors:  Priyamvada Paudyal; Carrie Llewellyn; Jason Lau; Mohammad Mahmud; Helen Smith
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  Acceptability and Feasibility of Self-Collecting Biological Specimens for HIV, Sexually Transmitted Infection, and Adherence Testing Among High-Risk Populations (Project Caboodle!): Protocol for an Exploratory Mixed-Methods Study.

Authors:  Akshay Sharma; Rob Stephenson; Gregory Sallabank; Leland Merrill; Stephen Sullivan; Monica Gandhi
Journal:  JMIR Res Protoc       Date:  2019-05-02

Review 9.  Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections.

Authors:  Luisa Fajardo-Bernal; Johanna Aponte-Gonzalez; Patrick Vigil; Edith Angel-Müller; Carlos Rincon; Hernando G Gaitán; Nicola Low
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

10.  The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial.

Authors:  K S Smith; J M Kaldor; J S Hocking; M S Jamil; A M McNulty; P Read; C S Bradshaw; M Y Chen; C K Fairley; H Wand; K Worthington; S Blake; V Knight; W Rawlinson; M Saville; S N Tabrizi; S M Garland; B Donovan; R Guy
Journal:  BMC Public Health       Date:  2016-01-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.